Plain-English translation of NCT02795052 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called bone marrow-derived stem cells (BMSC) for people with nervous system diseases or injuries. Researchers will collect stem cells from your bone marrow, then give them back to you through an IV infusion and by applying them to the inside of your nose. The hope is that these cells may help repair nerve damage and improve your symptoms.
Many nervous system conditions—like Parkinson's disease, ALS, stroke, and dementia—cause lasting damage that current medicines and surgeries can't reverse. This trial exists to see whether stem cells from your own bone marrow might repair that damage and restore some lost function.
You likely qualify if…
You likely don't qualify if…
If you qualify, your bone marrow will be collected through a procedure, and stem cells will be separated from it. You'll then receive these cells both through an IV infusion into your bloodstream and through application to the inside of your nasal passages (lower part of the nose). After treatment, you'll need to return for follow-up neurologic exams with the research team or your own neurologist to see if your symptoms improve. The study is still recruiting participants.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States
United Arab Emirates